AU628862B2 - Substituted n-vinyl imidazole derivatives - Google Patents

Substituted n-vinyl imidazole derivatives Download PDF

Info

Publication number
AU628862B2
AU628862B2 AU42431/89A AU4243189A AU628862B2 AU 628862 B2 AU628862 B2 AU 628862B2 AU 42431/89 A AU42431/89 A AU 42431/89A AU 4243189 A AU4243189 A AU 4243189A AU 628862 B2 AU628862 B2 AU 628862B2
Authority
AU
Australia
Prior art keywords
fluorophenyl
compounds
formula
group
methylethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU42431/89A
Other languages
English (en)
Other versions
AU4243189A (en
Inventor
Chuen Chan
Barry Clive Ross
Nigel Stephen Watson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888823191A external-priority patent/GB8823191D0/en
Priority claimed from GB888823192A external-priority patent/GB8823192D0/en
Priority claimed from GB898902847A external-priority patent/GB8902847D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU4243189A publication Critical patent/AU4243189A/en
Application granted granted Critical
Publication of AU628862B2 publication Critical patent/AU628862B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU42431/89A 1988-10-03 1989-10-02 Substituted n-vinyl imidazole derivatives Ceased AU628862B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB888823191A GB8823191D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB888823192A GB8823192D0 (en) 1988-10-03 1988-10-03 Chemical compounds
GB8823191 1988-10-03
GB8823192 1988-10-03
GB898902847A GB8902847D0 (en) 1989-02-09 1989-02-09 Chemical compounds
GB8902847 1989-02-09

Publications (2)

Publication Number Publication Date
AU4243189A AU4243189A (en) 1990-04-05
AU628862B2 true AU628862B2 (en) 1992-09-24

Family

ID=27264106

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42431/89A Ceased AU628862B2 (en) 1988-10-03 1989-10-02 Substituted n-vinyl imidazole derivatives

Country Status (19)

Country Link
US (2) US5013749A (OSRAM)
JP (1) JPH02188571A (OSRAM)
KR (1) KR900006297A (OSRAM)
AU (1) AU628862B2 (OSRAM)
BE (1) BE1003007A3 (OSRAM)
CH (1) CH680442A5 (OSRAM)
DE (1) DE3932887A1 (OSRAM)
DK (1) DK483689A (OSRAM)
ES (1) ES2019163A6 (OSRAM)
FI (1) FI894648A7 (OSRAM)
FR (1) FR2637183A1 (OSRAM)
GB (1) GB2223224B (OSRAM)
GR (1) GR890100634A (OSRAM)
IT (1) IT1237470B (OSRAM)
LU (1) LU87600A1 (OSRAM)
NL (1) NL8902441A (OSRAM)
NO (1) NO893909L (OSRAM)
PT (1) PT91878B (OSRAM)
SE (1) SE8903226L (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3913725A1 (de) * 1989-04-26 1990-10-31 Basf Ag 1-halogenvinyl-azole und diese enthaltende fungizide und wachstumsregulatoren
EP0422895A1 (en) * 1989-10-10 1991-04-17 Glaxo Group Limited Chemical compounds
PL361097A1 (en) * 2000-10-12 2004-09-20 Nissan Chemical Industries, Ltd. Preventives and remedies for complications of diabetes
IL158300A0 (en) * 2001-04-27 2004-05-12 Bristol Myers Squibb Co Bisarylimidazol derivatives and pharmaceutical compositions containing the same
KR20060133013A (ko) * 2004-04-16 2006-12-22 워너-램버트 캄파니 엘엘씨 신규 이미다졸
US20050282883A1 (en) * 2004-04-29 2005-12-22 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7163945B2 (en) * 2004-04-29 2007-01-16 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20060084695A1 (en) * 2004-04-29 2006-04-20 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7199126B2 (en) 2004-04-29 2007-04-03 Pharmix Corporation Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US7183285B2 (en) * 2004-04-29 2007-02-27 Pharmix Corp. Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
US20050272770A1 (en) * 2004-04-29 2005-12-08 John Griffin Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase
WO2005115397A2 (en) * 2004-04-29 2005-12-08 Pharmix Corporation Compositions and treatments for modulating kinase and/or hmg-coa reductase
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
US8372877B2 (en) 2010-04-16 2013-02-12 Cumberland Pharmaceuticals Stabilized statin formulations
EP2626069A4 (en) 2010-10-06 2014-03-19 Univ Tokyo Prophylactic and/or therapeutic agent against lymphedema

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
HUT48208A (en) * 1985-10-25 1989-05-29 Sandoz Ag Process for producing heterocyclic analogues of mevalolactone derivatives and pharmaceutical compositions comprising such compounds
EP0244364A3 (en) * 1986-04-30 1992-04-01 Sandoz Ag Preparation of olefinic compounds
DE3800785A1 (de) * 1988-01-09 1989-07-20 Hoechst Ag Substituierte 7-(pyridazin-5-yl)-3,5-dihydroxyheptan(en)- saeuren, ihre entsprechenden (delta)-lactone bzw. derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.

Also Published As

Publication number Publication date
AU4243189A (en) 1990-04-05
PT91878A (pt) 1990-04-30
CH680442A5 (OSRAM) 1992-08-31
KR900006297A (ko) 1990-05-07
DK483689A (da) 1990-04-04
NL8902441A (nl) 1990-05-01
DK483689D0 (da) 1989-10-02
SE8903226L (sv) 1990-04-04
FI894648A0 (fi) 1989-10-02
LU87600A1 (fr) 1990-05-15
FR2637183A1 (fr) 1990-04-06
DE3932887A1 (de) 1990-04-05
IT8948424A0 (it) 1989-10-02
GB2223224B (en) 1992-01-08
NO893909D0 (no) 1989-10-02
FI894648L (fi) 1990-04-04
SE8903226D0 (sv) 1989-10-02
BE1003007A3 (fr) 1991-10-22
IT1237470B (it) 1993-06-07
NO893909L (no) 1990-04-04
US5120848A (en) 1992-06-09
PT91878B (pt) 1995-05-31
JPH02188571A (ja) 1990-07-24
GR890100634A (el) 1990-11-29
FI894648A7 (fi) 1990-04-04
US5013749A (en) 1991-05-07
GB2223224A (en) 1990-04-04
GB8922212D0 (en) 1989-11-15
IT8948424A1 (it) 1991-04-02
ES2019163A6 (es) 1991-06-01

Similar Documents

Publication Publication Date Title
AU628862B2 (en) Substituted n-vinyl imidazole derivatives
KR960009434B1 (ko) 3-데메틸메발론산 유도체, 이의 제조방법 및 중간체
AU642127B2 (en) Substituted pyridines
US4931463A (en) Oxetanones
KR0142880B1 (ko) 3,5-디하이드록시헵트-6-인산의 7-치환된 유도체, 이의 제조방법 및 이를 포함하는 약제학적 생성물
FI96859B (fi) Menetelmä terapeuttisesti käyttökelpoisten fungisidisten triatsoliyhdisteiden valmistamiseksi
IE893987L (en) Substituted 2-pyridones and pyrid-2-thiones, processes for¹their preparation and their use in medicaments
JPH04210682A (ja) 酵素ＨＭＧ−ＣｏＡレダクターゼの抑制剤として活性な化合物ならびに該化合物を含む医薬組成物
DK157543B (da) Pyrazolanaloge af mevalonolacton og derivater deraf samt deres anvendelse
US5541203A (en) Triazole antifungal agents
US4308378A (en) Cis/trans isomerization of 6-(substituted-aryl-ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones
JPH03501613A (ja) ピリミジニル置換ヒドロキシ酸、ラクトン及びエステル並びにそれらを含む製薬学的組成物
HU208691B (en) Method for producing disubstituted pyridine derivatives and medical preparatives containing them
US5102893A (en) Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
EA009646B1 (ru) Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa
US20080280836A1 (en) Anti-hypercholesterolemic biaryl azetidinone compounds
US5112819A (en) Imidazole derivatives, pharmaceutical compositions and use
US5166213A (en) 4-pyridyl substituted-1,3-dioxane compounds
US4421758A (en) Anti-microbial diazole derivatives
AU622342B2 (en) Imino-substituted pyridines
HU208672B (en) Process for producing 7-(1h-pyrrol-3-yl)-substituted 3,5-dihydroxy-hepten acides and 3,5-dihydroxy-heptan acides and pharmaceutical preparations having these compounds as effective substance
US5248780A (en) Pyridyl substituted alkenoic acid derivatives
US5409910A (en) Substituted pyridines
AU630390B2 (en) Substituted 2-pyridones and pyrid-2-thiones, processes for their preparation and their use in medicaments
EP0303446B1 (en) Pyrroloisoquinolines